Family Med Journals

Family Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lombardi G et al. – Sildenafil represents an effective and safe long–term option for SCI subjects with ED. Further investigation of long–term use of oral PDE5 inhibitors in SCI patients is needed for evaluating both factors that are determinant in the choice of a starter treatment and in detecting elements that influence the switching from initial treatment.

Related Articles

Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09    Relevance Score: 70%

Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study
The Journal of Sexual Medicine, 10/28/09    Relevance Score: 69%

Evaluation of Microalbuminuria in Patients with Erectile Dysfunction
The Journal of Sexual Medicine, 10/07/09    Relevance Score: 69%

New Drug Udenafil for Erectile Dysfunction in US Trials
Internet Source, 11/10/09    Relevance Score: 68%

The Association of Serum Prolidase Activity and Erectile Dysfunction
Journal of Andrology, 10/23/09    Relevance Score: 68%

Today in Men`s Health...keeping you current

Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidence
Clinical Interventions in Aging, 12/19/09

The Effect of Perceived Racial Discrimination on Bodily Pain among Older African American Men
Pain Medicine, 12/15/09

Male breast cancer: A population-based comparison with female breast cancer
Journal of Clinical Oncology, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address